SLC7A11 and Parkinson disease: To assess the therapeutic potential of SLC7A11 overexpression in mitigating PD progression under diabetic conditions, we performed stereotaxic delivery of pAAV‐CMV‐mCherry‐P2A‐SLC7A11‐3xFLAG‐WPRE vectors into the substantia nigra of diabetic rats following 6‐OHDA administration.